Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 109, Issue 2, Pages 462-470
Publisher
Wiley
Online
2017-12-10
DOI
10.1111/cas.13467
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells
- (2017) Takatsugu Ishimoto et al. GASTROENTEROLOGY
- An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma
- (2016) Hasita Horlad et al. CANCER SCIENCE
- Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells
- (2016) Lubna M. Mehdawi et al. Molecular Oncology
- The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association
- (2015) R. Kridel et al. CLINICAL CANCER RESEARCH
- CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer
- (2015) Daisuke Izumi et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration
- (2015) Y. Zhang et al. SCIENCE
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions
- (2014) Mousumi Majumder et al. CANCER SCIENCE
- Chronic inflammation with Helicobacter pylori infection is implicated in CD44 overexpression through miR-328 suppression in the gastric mucosa
- (2014) Takatsugu Ishimoto et al. JOURNAL OF GASTROENTEROLOGY
- Monocyte Function in the Fetus and the Preterm Neonate: Immaturity Combined with Functional Impairment
- (2013) Zoe Iliodromiti et al. MEDIATORS OF INFLAMMATION
- Identification of miR-30e* Regulation of Bmi1 Expression Mediated by Tumor-Associated Macrophages in Gastrointestinal Cancer
- (2013) Hidetaka Sugihara et al. PLoS One
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection
- (2010) Sara Raimondi et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
- (2010) Horlad Hasita et al. CANCER SCIENCE
- Prostaglandin E2 Signaling and Bacterial Infection Recruit Tumor-Promoting Macrophages to Mouse Gastric Tumors
- (2010) Hiroko Oshima et al. GASTROENTEROLOGY
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
- (2010) Peter M Rothwell et al. LANCET
- CD44+slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2in gastric tumorigenesis
- (2009) Takatsugu Ishimoto et al. CANCER SCIENCE
- 15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Gastric Cancer
- (2009) A. Thiel et al. CLINICAL CANCER RESEARCH
- 15-Hydroxyprostaglandin Dehydrogenase is a Target of Hepatocyte Nuclear Factor 3 and a Tumor Suppressor in Lung Cancer
- (2008) G. Huang et al. CANCER RESEARCH
- Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
- (2008) Y Komohara et al. JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search